Drug Side Effects
Search
CARCINOMA IN SITU OF PENIS
CARCINOMA IN SITU OF PENIS
was reported 11 times
These drug classes are most commonly taken by patients reporting CARCINOMA IN SITU OF PENIS:
#
Drug
Count
0
Integrin Receptor Antagonist [EPC]
3
1
Tumor Necrosis Factor Blocker [EPC]
3
2
Angiotensin Converting Enzyme Inhibitor [EPC]
2
3
CD20-directed Cytolytic Antibody [EPC]
2
4
Corticosteroid [EPC]
2
5
Nonsteroidal Anti-inflammatory Drug [EPC]
2
6
Proton Pump Inhibitor [EPC]
2
7
Alkylating Drug [EPC]
1
8
Calcium Channel Blocker [EPC]
1
9
Dihydropyridine Calcium Channel Blocker [EPC]
1
10
HMG-CoA Reductase Inhibitor [EPC]
1
11
Interleukin-12 Antagonist [EPC]
1
12
Interleukin-23 Antagonist [EPC]
1
13
Platelet Aggregation Inhibitor [EPC]
1